Verastem, Inc. Defined Contribution Plan, Cost
Verastem, Inc. (VSTM) reported Defined Contribution Plan, Cost of $1.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-03-04
- Verastem, Inc. defined contribution plan, cost for fiscal 2025 was $1.30M, a 30.00% increase from fiscal 2024.
- Verastem, Inc. defined contribution plan, cost for fiscal 2024 was $1.00M, a 25.00% increase from fiscal 2023.
- Verastem, Inc. defined contribution plan, cost for fiscal 2023 was $800.00K, a 0.00% change from fiscal 2022.
- Verastem, Inc. defined contribution plan, cost for fiscal 2022 was $800.00K, a 0.00% change from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 5 month | Defined Contribution Plan, Cost 12 month | Defined Contribution Plan, Cost 12 month as first filed | Defined Contribution Plan, Cost 29 month | Defined Contribution Plan, Cost 36 month | Defined Contribution Plan, Cost 41 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.30M 10-K · filed 2026-03-04 | |||||
| 2024-12-31 | $1.00M 10-K · filed 2026-03-04 | |||||
| 2023-12-31 | $800.00K 10-K · filed 2026-03-04 | $800.00K 10-K · filed 2024-03-14 | ||||
| 2022-12-31 | $800.00K 10-K · filed 2025-03-20 | |||||
| 2021-12-31 | $800.00K 10-K · filed 2023-03-14 | |||||
| 2020-12-31 | $900.00K 10-K · filed 2023-03-14 | |||||
| 2019-12-31 | $1.30M 10-K · filed 2022-03-28 | |||||
| 2018-12-31 | $800.00K 10-K · filed 2021-03-18 | |||||
| 2017-12-31 | $300.00K 10-K · filed 2020-03-11 | $273.00K 10-K · filed 2018-03-13 | ||||
| 2016-12-31 | $200.00K 10-K · filed 2019-03-12 | $162.00K 10-K · filed 2017-03-23 | ||||
| 2015-12-31 | $295.00K 10-K · filed 2018-03-13 | |||||
| 2014-12-31 | $219.00K 10-K · filed 2017-03-23 | |||||
| 2013-12-31 | $160.00K 10-K · filed 2016-03-03 | $322.00K 10-K · filed 2014-03-06 | ||||
| 2012-12-31 | $116.00K 10-K · filed 2015-03-10 | $162.00K 10-K · filed 2013-03-26 | ||||
| 2011-12-31 | $46.00K 10-K · filed 2014-03-06 | |||||
| 2010-12-31 | $0.00 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |